NUKETO®
DESCRIPTION
NUKETO® is a therapy for treatment of Chronic Kidney Disease(CKD) wherein patients are on conservative management especially when there is some residual kidney function left in stage I, II and III of Chronic Kidney Disease(CKD). NUKETO®, a combination of alpha keto amino acids and essential amino acids given to patients with very low protein or a low protein diet to delay the progression of CKD.
INDICATION
NUKETO® is indicated in prevention and therapy of damages due to faulty or deficient protein metabolism in chronic renal insufficiency
DOSAGE
One tablet of NUKETO® per 5kg/body weight/day during meals every day for entire duration as prescribed by health care specialist.
BENEFITS
NUKETO® in combination with very low protein/low protein diet helps in delaying the progression of CKD by preventing the degradation of body proteins, reducing urinary protein excretion and normalizing the carbohydrate metabolism.
Each NUKETO® tablet contains
| Calcium 3-methy-2oxo-valerate | (α-ketoanalogue of isoleucine,calcium salt) | 67 mg |
| Calcium 4-methy-2oxo-valerate | (α-ketoanalogue of leucine,calcium salt) | 101 mg |
| Calcium-2-oxo-3-phenylpropionate | (α-ketoanalogue of phenylalaline,calcium salt) | 68 mg |
| Calcium-3-methyl-2-oxo-butyrate | (α-ketoanalogue of valine,calcium salt) | 86 mg |
| Calcium-DL-2-hydroxy-4(methylthio) butyrate | (α-hydroxyanalogue of methionine,calcium salt) | 59 mg |
| L-Lysine Acetate | USP | 105 mg |
| L-Threonine | USP | 53 mg |
| L-Tryptophan | USP | 23 mg |
| L-Histidine | USP | 38 mg |
| L-Tyrosine | USP | 30 mg |
| Total Nitrogen Content /Tablet | 36 mg | |
| Calcium Content/Tablet | 1.25 mmol=^ 0.05 gm |
Disclaimer:
The information given above is for general awareness and by no means intended to be seen as medical advice or replacement of medical advice. Please consult your health care specialist for medical advice.